PROCEPT BioRobotics Receivables 2021-2025 | PRCT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

PROCEPT BioRobotics receivables from 2021 to 2025. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

PROCEPT BioRobotics receivables from 2021 to 2025. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$179.3B
Intuitive Surgical (ISRG)	$175.2B
Alcon (ALC)	$45.3B
Edwards Lifesciences (EW)	$44.5B
IDEXX Laboratories (IDXX)	$44.2B
IQVIA Holdings (IQV)	$34.1B
DexCom (DXCM)	$34B
Mettler-Toledo (MTD)	$26.2B
STERIS (STE)	$22.4B
Waters (WAT)	$17.8B
SONOVA HOLDING (SONVY)	$17.5B
Hologic (HOLX)	$14.7B
Sysmex ADR (SSMXY)	$10.9B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.7B
Globus Medical (GMED)	$7.2B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.1B
Integer Holdings (ITGR)	$3.7B
TransMedics (TMDX)	$3.6B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B
Tandem Diabetes Care (TNDM)	$1B
Pulse Biosciences (PLSE)	$1B